INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 186 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $402,000 | -82.6% | 5,050 | -81.6% | 0.01% | -84.1% |
| Q2 2018 | $2,308,000 | +87.5% | 27,500 | +170.4% | 0.04% | +83.3% |
| Q2 2017 | $1,231,000 | +354.2% | 10,169 | +323.7% | 0.02% | +380.0% |
| Q1 2017 | $271,000 | -87.2% | 2,400 | -87.6% | 0.01% | -87.5% |
| Q4 2016 | $2,120,000 | +151.8% | 19,400 | +228.8% | 0.04% | +263.6% |
| Q2 2016 | $842,000 | -20.6% | 5,900 | -28.5% | 0.01% | -15.4% |
| Q1 2016 | $1,061,000 | -16.4% | 8,250 | -2.9% | 0.01% | +62.5% |
| Q4 2015 | $1,269,000 | +350.0% | 8,500 | +750.0% | 0.01% | +700.0% |
| Q1 2015 | $282,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |